Open Recommendations
Recommendation Number | Significant Recommendation | Recommended Questioned Costs | Recommended Funds for Better Use | Additional Details | |
---|---|---|---|---|---|
6982 | No | $0 | $0 | ||
CMS should monitor national EPSDT performance data for blood lead screening tests and target efforts toward low-performing States to develop action plans for increasing tests, according toMedicaid's schedule | |||||
6983 | No | $0 | $0 | ||
CMS should ensure consistency across CMS guidance related to actionable blood lead reference values and blood lead screening test definitions. | |||||
6984 | No | $0 | $0 | ||
CMS should coordinate with partners to develop and disseminate to State Medicaid agencies educational materials that reaffirmrequirements and schedules for blood lead screening tests |